Supplement For Chronic Hepatitis B Patients

Menu

Best Sale

FEBICO (Taiwan Microalgae Manufacturer) Supplement For Chronic Hepatitis B Patients Introduction

Far East Bio-Tec Co., Ltd. (ALGAPHARMA BIOTECH CORP.) is Taiwan supplier and manufacturer in organic spirulina, organic chlorella producer and biotech microalgae research market. FEBICO (Taiwan Microalgae Manufacturer) has been offering our customers high value spirulina, chlorella, spirulina chlorella, organic spirulina, organic chlorella, bio chlorella, blue green algae, nutritional supplements since 1976. With both advanced technology and 40 years experience, FEBICO (Taiwan Microalgae Manufacturer) always make sure to meet each customer's demand.

Supplement For Chronic Hepatitis B Patients

2018/07/03 FEBICO
Dr. Ming Shun Wu is a world-renowned expert in gastroenterology and biotechnology. Here giving a speech about FEM-102 at a medical conference.
Dr. Ming Shun Wu is a world-renowned expert in gastroenterology and biotechnology. Here giving a speech about FEM-102 at a medical conference.

Viral hepatitis has been a fundamental problem in Taiwan, especially hepatitis B. There is no cure for Hepatitis B and infected patients have to take medicine for the rest of their lives to control the virus.

The Disease Control Agency said that presently there are about 2.8-3.3 million hepatitis B virus carriers in Taiwan. Those carriers are 150 times more likely to develop liver cancer than healthy people.

New Way To Fight Hepatitis B
A recent clinical research team led by Dr. Wu Ming-shun, director of the Department of Gastroenterology, Wanfang Hospital, found that supplementing Taiwan-specific Arthrospira when treating patients with hepatitis B can effectively reduce the hepatitis B surface antigen (anti-HBs).

Dr. Ming Shun Wu is a world-renowned expert in gastroenterology and biotechnology. Here giving a speech about FEM-102 at a medical conference.

This clinical trial is still ongoing, and it awaits publication in medical journals. Taiwan-specific Arthrospira FEM-102, in the non-clinical trials, has shown to be effective in increasing immunity and resistance to virus infections. Currently, Arthrospira FEM-102 is being developed by the domestic industry into dietary supplements.

Wanfang Hospital’s Gastroenterology team recruited 60 volunteers infected with Hepatitis B to participate in the test. In addition to drugs, the patients were administered different doses of Arthrospira FEM-102. After 6 months, blood tests found that patients taking 6 grams of FEM-102 daily showed a significant reduction in hepatitis B surface antigen (anti-HBs).

New Hope to Hepatitis B Patients
Current medication cannot eliminate hepatitis B completely. Only a small portion of infected childer can be completely cured. The rest of the patients are facing life-long intake of anti-viral drugs to control hepatitis B virus. Often, the older the patient, the harder it is to control hepatitis.

The emergence of the unique Arthrospira FEM-102 brings new hope to hepatitis B patients, especially those over 50 with the chronic form of hepatitis.